Globulin, gamma-globulin or IgG level ≥ 1.5 times upper limit of normal ANA, SMA, or anti-LKM1 ≥ 1:80 in adults and ≥ 1:20 in children; no AMA Hypergammaglobulinemia of any degree ANA, SMA or ...

Patients with autoimmune hepatitis have no increased long-term risk for psychiatric disorders compared with the general population.

Autoimmune hepatitis (AIH) is a complex, chronic inflammatory liver disorder in which the body's immune system aberrantly targets hepatocytes, leading to progressive hepatic injury. Characterised by ...

Autoimmune hepatitis affects a diverse group of patients, and medical management is largely successful in controlling progression and prolonging survival. Alternative agents such as MMF have yet to ...

Autoimmune hepatitis quietly damages the liver for years before symptoms appear; specialists in Kenya warn of late diagnoses and urge early medical checks. [File, Standard] When people think about ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In this video, Nancy S. Reau, MD, FAASLD, AGAF, speaks with Healio about findings from a systemic ...

Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that the ...

Khat (Catha edulis) is a plant native to East Africa and the Arabian Peninsula, chewed for its stimulant effects by millions worldwide. Its sympathomimetic properties, primarily due to cathinone and ...

A major retrospective study shows that people with blood group A face a higher likelihood of autoimmune liver disease, especially primary biliary cholangitis, while those with blood group B appear ...

Hepatitis is an inflammation of the liver. It’s considered acute until it lasts six months, at which point it’s considered chronic. Complications that can develop from chronic hepatitis include a ...

FDA placed Kezar’s lupus nephritis drug on clinical hold after four fatal adverse events. Kezar says the autoimmune hepatitis trial remains unaffected. Feel unsure about the market’s next move? Copy ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in ...